Loading…
The disease relevance of human hepatocellular xenograft models: Molecular characterization and review of the literature
Abstract In recent years a number of new therapeutics has been developed that were not general toxins and inhibitors of cell division like classical chemotherapeutics, but were designed to target a specific pathway. A prerequisite for this development was the comprehensive characterization of molecu...
Saved in:
Published in: | Cancer letters 2009-12, Vol.286 (1), p.121-128 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c443t-67dc09a99d75e5af346a4f50a43de65c8c08b66bcd3684e39b1fd79d5ce658f23 |
---|---|
cites | cdi_FETCH-LOGICAL-c443t-67dc09a99d75e5af346a4f50a43de65c8c08b66bcd3684e39b1fd79d5ce658f23 |
container_end_page | 128 |
container_issue | 1 |
container_start_page | 121 |
container_title | Cancer letters |
container_volume | 286 |
creator | Kashofer, K Tschernatsch, M.M Mischinger, H.J Iberer, F Zatloukal, K |
description | Abstract In recent years a number of new therapeutics has been developed that were not general toxins and inhibitors of cell division like classical chemotherapeutics, but were designed to target a specific pathway. A prerequisite for this development was the comprehensive characterization of molecular alterations occurring in human hepatocellular carcinoma (HCC). However, while much knowledge of the molecular pathogenesis of human HCC has been gained, the model systems used to test the functional relevance of these alterations and applied for preclinical evaluation of drug candidates are still poorly characterized. In this paper, we reviewed the literature about several commonly used HCC cell lines and xenotransplantation models and present our own data on the molecular characterization of these. Results obtained demonstrate that it is important to have a sound knowledge of the specific molecular constitution of the experimental model and to carefully evaluate the functional status of the pathway of interest. For this reason, we make the gene expression profiles publicly available to help researchers making an informed decision about which model to use. |
doi_str_mv | 10.1016/j.canlet.2008.11.011 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66636523</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0304383508008720</els_id><sourcerecordid>66636523</sourcerecordid><originalsourceid>FETCH-LOGICAL-c443t-67dc09a99d75e5af346a4f50a43de65c8c08b66bcd3684e39b1fd79d5ce658f23</originalsourceid><addsrcrecordid>eNqFkk1v1DAQhi0EotuFf4BQJCRuCXYcOw4HJFRRQCriQDlbs_aE9eKNF9tpKb8eh12pUi-c5jDvvPPxDCEvGG0YZfLNrjEwecxNS6lqGGsoY4_Iiqm-rftB0cdkRTntaq64OCPnKe0opaLrxVNyxgbGGFfDitxeb7GyLiEkrCJ6vIHJYBXGajvvYaq2eIAcDHo_e4jVb5zCjwhjrvbBok9vqy_Bo_mXM1uIYDJG9weyC1MFky2WNw5vF79cGnlX0pDniM_IkxF8wuenuCbfLz9cX3yqr75-_Hzx_qo2XcdzLXtr6ADDYHuBAkbeSehGQaHjFqUwylC1kXJjLJeqQz5s2Gj7wQpTsmps-Zq8PvoeYvg1Y8p679KyDkwY5qSllFyKlhfhqwfCXZjjVGbTTFAxtK0oE61Jd1SZGFKKOOpDdHuId5pRvWDRO33EohcsmjFdsJSylyfzebNHe1904lAE746CctPlYlEn47CQsC6iydoG978ODw2Md5Mz4H_iHab7XXRqNdXfltdYPoOqYtK3lP8F2iK21g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1505922544</pqid></control><display><type>article</type><title>The disease relevance of human hepatocellular xenograft models: Molecular characterization and review of the literature</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Kashofer, K ; Tschernatsch, M.M ; Mischinger, H.J ; Iberer, F ; Zatloukal, K</creator><creatorcontrib>Kashofer, K ; Tschernatsch, M.M ; Mischinger, H.J ; Iberer, F ; Zatloukal, K</creatorcontrib><description>Abstract In recent years a number of new therapeutics has been developed that were not general toxins and inhibitors of cell division like classical chemotherapeutics, but were designed to target a specific pathway. A prerequisite for this development was the comprehensive characterization of molecular alterations occurring in human hepatocellular carcinoma (HCC). However, while much knowledge of the molecular pathogenesis of human HCC has been gained, the model systems used to test the functional relevance of these alterations and applied for preclinical evaluation of drug candidates are still poorly characterized. In this paper, we reviewed the literature about several commonly used HCC cell lines and xenotransplantation models and present our own data on the molecular characterization of these. Results obtained demonstrate that it is important to have a sound knowledge of the specific molecular constitution of the experimental model and to carefully evaluate the functional status of the pathway of interest. For this reason, we make the gene expression profiles publicly available to help researchers making an informed decision about which model to use.</description><identifier>ISSN: 0304-3835</identifier><identifier>EISSN: 1872-7980</identifier><identifier>DOI: 10.1016/j.canlet.2008.11.011</identifier><identifier>PMID: 19111389</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>Animals ; Cancer therapies ; Carcinoma, Hepatocellular - genetics ; Carcinoma, Hepatocellular - pathology ; Carcinoma, Hepatocellular - surgery ; Cell cycle ; Gene expression ; Gene expression profiles ; HCC ; Hematology, Oncology and Palliative Medicine ; Hepatocellular carcinoma ; Humans ; Kinases ; Liver cancer ; Liver Neoplasms - genetics ; Liver Neoplasms - pathology ; Liver Neoplasms - surgery ; Medical prognosis ; Medical research ; Mice ; Mice, Nude ; Models, Biological ; Patients ; Studies ; Transplantation, Heterologous ; Tumors ; Vascular endothelial growth factor ; Xenografts</subject><ispartof>Cancer letters, 2009-12, Vol.286 (1), p.121-128</ispartof><rights>Elsevier Ireland Ltd</rights><rights>2008 Elsevier Ireland Ltd</rights><rights>Copyright Elsevier Limited Dec 1, 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c443t-67dc09a99d75e5af346a4f50a43de65c8c08b66bcd3684e39b1fd79d5ce658f23</citedby><cites>FETCH-LOGICAL-c443t-67dc09a99d75e5af346a4f50a43de65c8c08b66bcd3684e39b1fd79d5ce658f23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19111389$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kashofer, K</creatorcontrib><creatorcontrib>Tschernatsch, M.M</creatorcontrib><creatorcontrib>Mischinger, H.J</creatorcontrib><creatorcontrib>Iberer, F</creatorcontrib><creatorcontrib>Zatloukal, K</creatorcontrib><title>The disease relevance of human hepatocellular xenograft models: Molecular characterization and review of the literature</title><title>Cancer letters</title><addtitle>Cancer Lett</addtitle><description>Abstract In recent years a number of new therapeutics has been developed that were not general toxins and inhibitors of cell division like classical chemotherapeutics, but were designed to target a specific pathway. A prerequisite for this development was the comprehensive characterization of molecular alterations occurring in human hepatocellular carcinoma (HCC). However, while much knowledge of the molecular pathogenesis of human HCC has been gained, the model systems used to test the functional relevance of these alterations and applied for preclinical evaluation of drug candidates are still poorly characterized. In this paper, we reviewed the literature about several commonly used HCC cell lines and xenotransplantation models and present our own data on the molecular characterization of these. Results obtained demonstrate that it is important to have a sound knowledge of the specific molecular constitution of the experimental model and to carefully evaluate the functional status of the pathway of interest. For this reason, we make the gene expression profiles publicly available to help researchers making an informed decision about which model to use.</description><subject>Animals</subject><subject>Cancer therapies</subject><subject>Carcinoma, Hepatocellular - genetics</subject><subject>Carcinoma, Hepatocellular - pathology</subject><subject>Carcinoma, Hepatocellular - surgery</subject><subject>Cell cycle</subject><subject>Gene expression</subject><subject>Gene expression profiles</subject><subject>HCC</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Hepatocellular carcinoma</subject><subject>Humans</subject><subject>Kinases</subject><subject>Liver cancer</subject><subject>Liver Neoplasms - genetics</subject><subject>Liver Neoplasms - pathology</subject><subject>Liver Neoplasms - surgery</subject><subject>Medical prognosis</subject><subject>Medical research</subject><subject>Mice</subject><subject>Mice, Nude</subject><subject>Models, Biological</subject><subject>Patients</subject><subject>Studies</subject><subject>Transplantation, Heterologous</subject><subject>Tumors</subject><subject>Vascular endothelial growth factor</subject><subject>Xenografts</subject><issn>0304-3835</issn><issn>1872-7980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNqFkk1v1DAQhi0EotuFf4BQJCRuCXYcOw4HJFRRQCriQDlbs_aE9eKNF9tpKb8eh12pUi-c5jDvvPPxDCEvGG0YZfLNrjEwecxNS6lqGGsoY4_Iiqm-rftB0cdkRTntaq64OCPnKe0opaLrxVNyxgbGGFfDitxeb7GyLiEkrCJ6vIHJYBXGajvvYaq2eIAcDHo_e4jVb5zCjwhjrvbBok9vqy_Bo_mXM1uIYDJG9weyC1MFky2WNw5vF79cGnlX0pDniM_IkxF8wuenuCbfLz9cX3yqr75-_Hzx_qo2XcdzLXtr6ADDYHuBAkbeSehGQaHjFqUwylC1kXJjLJeqQz5s2Gj7wQpTsmps-Zq8PvoeYvg1Y8p679KyDkwY5qSllFyKlhfhqwfCXZjjVGbTTFAxtK0oE61Jd1SZGFKKOOpDdHuId5pRvWDRO33EohcsmjFdsJSylyfzebNHe1904lAE746CctPlYlEn47CQsC6iydoG978ODw2Md5Mz4H_iHab7XXRqNdXfltdYPoOqYtK3lP8F2iK21g</recordid><startdate>20091201</startdate><enddate>20091201</enddate><creator>Kashofer, K</creator><creator>Tschernatsch, M.M</creator><creator>Mischinger, H.J</creator><creator>Iberer, F</creator><creator>Zatloukal, K</creator><general>Elsevier Ireland Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20091201</creationdate><title>The disease relevance of human hepatocellular xenograft models: Molecular characterization and review of the literature</title><author>Kashofer, K ; Tschernatsch, M.M ; Mischinger, H.J ; Iberer, F ; Zatloukal, K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c443t-67dc09a99d75e5af346a4f50a43de65c8c08b66bcd3684e39b1fd79d5ce658f23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Cancer therapies</topic><topic>Carcinoma, Hepatocellular - genetics</topic><topic>Carcinoma, Hepatocellular - pathology</topic><topic>Carcinoma, Hepatocellular - surgery</topic><topic>Cell cycle</topic><topic>Gene expression</topic><topic>Gene expression profiles</topic><topic>HCC</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Hepatocellular carcinoma</topic><topic>Humans</topic><topic>Kinases</topic><topic>Liver cancer</topic><topic>Liver Neoplasms - genetics</topic><topic>Liver Neoplasms - pathology</topic><topic>Liver Neoplasms - surgery</topic><topic>Medical prognosis</topic><topic>Medical research</topic><topic>Mice</topic><topic>Mice, Nude</topic><topic>Models, Biological</topic><topic>Patients</topic><topic>Studies</topic><topic>Transplantation, Heterologous</topic><topic>Tumors</topic><topic>Vascular endothelial growth factor</topic><topic>Xenografts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kashofer, K</creatorcontrib><creatorcontrib>Tschernatsch, M.M</creatorcontrib><creatorcontrib>Mischinger, H.J</creatorcontrib><creatorcontrib>Iberer, F</creatorcontrib><creatorcontrib>Zatloukal, K</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kashofer, K</au><au>Tschernatsch, M.M</au><au>Mischinger, H.J</au><au>Iberer, F</au><au>Zatloukal, K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The disease relevance of human hepatocellular xenograft models: Molecular characterization and review of the literature</atitle><jtitle>Cancer letters</jtitle><addtitle>Cancer Lett</addtitle><date>2009-12-01</date><risdate>2009</risdate><volume>286</volume><issue>1</issue><spage>121</spage><epage>128</epage><pages>121-128</pages><issn>0304-3835</issn><eissn>1872-7980</eissn><abstract>Abstract In recent years a number of new therapeutics has been developed that were not general toxins and inhibitors of cell division like classical chemotherapeutics, but were designed to target a specific pathway. A prerequisite for this development was the comprehensive characterization of molecular alterations occurring in human hepatocellular carcinoma (HCC). However, while much knowledge of the molecular pathogenesis of human HCC has been gained, the model systems used to test the functional relevance of these alterations and applied for preclinical evaluation of drug candidates are still poorly characterized. In this paper, we reviewed the literature about several commonly used HCC cell lines and xenotransplantation models and present our own data on the molecular characterization of these. Results obtained demonstrate that it is important to have a sound knowledge of the specific molecular constitution of the experimental model and to carefully evaluate the functional status of the pathway of interest. For this reason, we make the gene expression profiles publicly available to help researchers making an informed decision about which model to use.</abstract><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>19111389</pmid><doi>10.1016/j.canlet.2008.11.011</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0304-3835 |
ispartof | Cancer letters, 2009-12, Vol.286 (1), p.121-128 |
issn | 0304-3835 1872-7980 |
language | eng |
recordid | cdi_proquest_miscellaneous_66636523 |
source | ScienceDirect Freedom Collection 2022-2024 |
subjects | Animals Cancer therapies Carcinoma, Hepatocellular - genetics Carcinoma, Hepatocellular - pathology Carcinoma, Hepatocellular - surgery Cell cycle Gene expression Gene expression profiles HCC Hematology, Oncology and Palliative Medicine Hepatocellular carcinoma Humans Kinases Liver cancer Liver Neoplasms - genetics Liver Neoplasms - pathology Liver Neoplasms - surgery Medical prognosis Medical research Mice Mice, Nude Models, Biological Patients Studies Transplantation, Heterologous Tumors Vascular endothelial growth factor Xenografts |
title | The disease relevance of human hepatocellular xenograft models: Molecular characterization and review of the literature |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T17%3A41%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20disease%20relevance%20of%20human%20hepatocellular%20xenograft%20models:%20Molecular%20characterization%20and%20review%20of%20the%20literature&rft.jtitle=Cancer%20letters&rft.au=Kashofer,%20K&rft.date=2009-12-01&rft.volume=286&rft.issue=1&rft.spage=121&rft.epage=128&rft.pages=121-128&rft.issn=0304-3835&rft.eissn=1872-7980&rft_id=info:doi/10.1016/j.canlet.2008.11.011&rft_dat=%3Cproquest_cross%3E66636523%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c443t-67dc09a99d75e5af346a4f50a43de65c8c08b66bcd3684e39b1fd79d5ce658f23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1505922544&rft_id=info:pmid/19111389&rfr_iscdi=true |